Fortis Healthcare Ltd Share Price
Hospitals / Medical Services
As on 31 January 2025 at 13:49 IST
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is India's leading integrated healthcare delivery service provider. It operates in multi-specialty hospitals, diagnostic centers, and specialized care facilities. Fortis was founded in 1996 by Malvinder Singh and Shivinder Singh. The company underwent a significant change in 2018 when IHH Healthcare Berhad became its backing entity. It is headquartered in Mohali, Punjab. Fortis Healthcare offers comprehensive healthcare services. This includes multi-specialty hospital care, daycare specialty facilities, and diagnostic and emergency services. Operating in the Healthcare Services sector, Fortis manages a network of several healthcare facilities across India. Read More...
The Fortis Healthcare Ltd prices are delayed, login to your account for live prices
LOGINOver 1 Month
-10.75%
Over 6 Months
28.98%
Over 1 Year
54.23%
Over 3 Years
139.64%
Fortis Healthcare Ltd Summary
Close
₹
648.55
Open
₹
647.50
High
₹
654.90
Low
₹
628.80
Volume
11,58,316
Net Turnover (in ₹ Cr)
₹
119.88
52Wk High
₹
744.50
52Wk Low
₹
375.05
52Wk High / Low
375.05
744.50
Fortis Healthcare Ltd Fundamentals
Key Financial Data
Market Cap (in ₹Cr)
₹
48,902.41
EPS (TTM)
2.51
Book Value (BV)
120.24
Div. Yield
0.15
%
P/E (TTM)
310.24
Price/Book Value
5.39
Delivery %
45.76
%
Face Value
10
Key Ratios
PE Ratio
159.05
PB Ratio
3.49
EV to Sales
26.29
PEG Ratio
1.47
ROA
2.04
ROE
1.37
Debt-Equity
0.08
Net Profit Margin
10.11
Operating Profit Margin
27.42
Fortis Healthcare Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 6,931.17 | 6,359.35 | 5,744.95 | 4,076.68 | 4,684.96 |
| Total Expenses | 6,098.73 | 5,641.12 | 5,096.34 | 4,082.15 | 4,519.59 |
| Profit Before Tax | 857.97 | 813.68 | 987.79 | 43.30 | 239.36 |
| Profit After Tax | 645.22 | 632.98 | 789.95 | -56.17 | 91.49 |
| Operating Profit after Depreciation | 963.38 | 847.32 | 795.45 | 160.41 | 370.43 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 9,875.18 | 9,426.48 | 9,415.75 | 8,800.86 | 8,817.26 |
| Total Non Current Assets | 11,868.19 | 11,027.25 | 10,751.48 | 10,117.88 | 10,407.34 |
| Total Current Assets | 1,420.59 | 1,406.35 | 1,133.27 | 1,036.80 | 940.48 |
| TOTAL ASSETS | 13,288.78 | 12,433.60 | 11,884.75 | 11,154.69 | 11,347.82 |
| Total Shareholder's Fund | 7,662.90 | 7,242.26 | 6,178.24 | 6,119.81 | 6,661.09 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1,100.10 | 822.25 | 865.39 | 485.49 | 171.54 |
| Net Cash used in Investing Activities | -889.12 | -372.48 | -500.61 | -130.55 | 63.48 |
| Net Cash used in Financing Activities | -86.46 | -471.22 | -517.31 | -142.93 | -861.61 |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 1,324.43 | 1,202.50 | 996.71 | 824.85 | 1,640.19 |
| Total Expenses | 1,171.51 | 1,141.90 | 989.41 | 857.18 | 890.89 |
| Profit Before Tax | 246.56 | 108.88 | -8.99 | 24.13 | 620.68 |
| Profit After Tax | 199.45 | 96.24 | -13.25 | 4.20 | 513.33 |
| Operating Profit after Depreciation | 234.83 | 166.84 | 136.87 | 109.12 | 909.47 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 468.13 | 491.86 | 770.28 | 853.25 | 909.85 |
| Total Non Current Assets | 9,745.42 | 9,678.55 | 10,020.52 | 10,196.70 | 10,222.14 |
| Total Current Assets | 641.50 | 690.12 | 405.69 | 385.44 | 358.72 |
| TOTAL ASSETS | 10,386.91 | 10,368.67 | 10,426.21 | 10,582.14 | 10,580.86 |
| Total Shareholder's Fund | 9,087.16 | 8,963.54 | 8,868.56 | 8,881.53 | 8,876.47 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | 218.45 | 198.38 | 76.49 | 31.94 | 99.92 |
| Net Cash used in Investing Activities | 44.46 | 204.62 | 237.74 | 28.40 | 810.04 |
| Net Cash used in Financing Activities | -245.35 | -395.43 | -319.83 | 5.91 | -971.53 |
| Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
|---|---|---|---|---|---|
| Total Revenue | 1,988.39 | 1,858.90 | 1,785.88 | 1,679.68 | 1,769.95 |
| Total Expenses | 1,553.56 | 1,516.38 | 1,404.84 | 1,395.71 | 1,439.78 |
| Profit Before Tax | 261.05 | 230.05 | 271.38 | 183.15 | 232.71 |
| Profit After Tax | 193.08 | 173.98 | 203.14 | 134.23 | 183.90 |
| Operating Profit after Depreciation | 452.30 | 356.12 | 395.16 | 295.31 | 344.95 |
| Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
|---|---|---|---|---|---|
| Total Revenue | 357.15 | 333.40 | 307.48 | 290.75 | 294.12 |
| Total Expenses | 297.30 | 275.46 | 238.18 | 242.01 | 254.51 |
| Profit Before Tax | 52.01 | 50.50 | 89.61 | 35.79 | 103.50 |
| Profit After Tax | 39.63 | 26.83 | 68.33 | 22.94 | 95.30 |
| Operating Profit after Depreciation | 164.02 | 93.37 | 101.80 | 80.41 | 87.84 |
Fortis Healthcare Ltd Technicals
Support and Resistance
S3
S2
S1
Pivot
R1
R2
R3
S1
631.67
S2
615.58
S3
604.17
Pivot
643.08
R1
659.17
R2
670.58
R3
686.67
Moving Average
20 SMA
661.03
50 SMA
679.82
100 SMA
642.51
200 SMA
562.11
Fortis Healthcare Ltd Corporate Actions
Fortis Healthcare Ltd
₹1/Share
Announcement Date
24 Jul 2024
Record Date
24 Jul 2024
Div Yield
10%
Fortis Healthcare Ltd Peer Comparison
| Company | Price | Market Cap (in ₹ Cr) |
|---|---|---|
| Fortis Healthcare Ltd | ₹648.40 | ₹48,951.49 |
| Max Healthcare Institute Ltd | ₹1,042.60 | ₹1,01,354.49 |
| Apollo Hospitals Enterprise Ltd | ₹6,827.55 | ₹98,169.69 |
| Syngene International Ltd | ₹758.45 | ₹30,530.42 |
| Global Health Ltd | ₹1,048 | ₹28,147.96 |
| Narayana Hrudayalaya Ltd | ₹1,302.75 | ₹26,623.10 |
Fortis Healthcare Ltd News
Fortis Healthcare to convene board meeting
On 7 February 2025
29 Jan 2025, 03:19 pm
Fortis Healthcare rises on appointing Leo Puri as chairman
Fortis Healthcare added 1.12% to Rs 679.45 after the company's board approved the appointment of Leo Puri as the chairman of the board with effect from today 27 December 2024.
27 Dec 2024, 02:18 pm
Fortis Healthcare rises as Q2 PAT climbs 5% YoY to Rs 193 cr
Fortis Healthcare advanced 1.02% to Rs 627.25 after the company reported a 4.99% gain in consolidated net profit to Rs 193.08 crore on 12.34% jump in revenue from operations to Rs 1,988.39 crore in Q2 FY25 over Q2 FY24.
11 Nov 2024, 09:58 am
Fortis Healthcare to announce Quarterly Result
On 8 November 2024
31 Oct 2024, 12:07 pm
Board of Fortis Healthcare approves NCD issuance of Rs 1550 cr
At meeting held on 09 October 2024
10 Oct 2024, 09:56 am
Fortis Healthcare Ltd Stock Analysis
- Annual revenue for Fortis Healthcare Ltd increased by 10.14% to ₹1,324.43 crore in FY 2024 from ₹1,202.50 crore in FY 2023.
- Annual Net Profit for Fortis Healthcare Ltd increased by 107.25% to ₹199.45 crore in FY 2024 from ₹96.24 crore in FY 2023.
- Promoter Shareholding in Fortis Healthcare Ltd remains unchanged by 0.00% in the most recent quarter, from 31.17% in September 2024 to 31.17% in December 2024.
- Fortis Healthcare Ltd delivered a 1-year return of 54.23% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
- Fortis Healthcare Ltd share price moved up by 0.12% from its previous close of INR ₹647.75. The latest Fortis Healthcare Ltd share price is INR ₹648.55.
- Fortis Healthcare Ltd share price today has been at a low of 628.80 and a high of 654.90. Over the past 52 weeks, the Fortis Healthcare Ltd share price has seen a low of 375.05 and a high of 744.50.
About Fortis Healthcare Ltd
Fortis Healthcare Ltd. is India's leading integrated healthcare delivery service provider. It operates in multi-specialty hospitals, diagnostic centers, and specialized care facilities. The company is especially operating in the Hospital & Healthcare Services industry.
Fortis Healthcare was founded in 1996 by Malvinder Singh and Shivinder Singh. The company has been providing healthcare services for many decades. Following a change in ownership in 2018, the company is now backed by IHH Healthcare Berhad, one of Asia's largest healthcare groups. Fortis Healthcare is headquartered in Mohali, Punjab, India.
The promoter shareholding of the company is 31.17%. The company's promoter is Northern TK Venture Pte Ltd., a subsidiary of IHH Healthcare Berhad. The company offers a comprehensive range of healthcare services. This includes multi-specialty hospital care, Diagnostic services, and Daycare specialty facilities. It also offers emergency services, critical care, preventive health programs, and organ transplantation.
Fortis Healthcare is among the top private healthcare providers in India. But it ranks second in terms of market capitalization after Apollo Hospitals Enterprise Ltd. The company operates a network of many healthcare facilities with approximately 4,000 operational beds across India.
The company's registered office is at Fortis Hospital, Sector 62, Phase VIII, Mohali, Punjab - 160062. Its registrar is located in Hyderabad, Telangana. The registrar & transfer agent of Fortis Healthcare is KFin Technologies Limited. Ravi Rajagopal is the company's chairperson and independent director.
The company's other vital managerial promoters include:
The company continues expanding its presence across India through organic and inorganic growth strategies.
Healthcare Access and Infrastructure Impact
Fortis has significantly impacted healthcare accessibility in India through its network of many hospitals across major cities and tier-2 locations. The company has brought world-class medical infrastructure to various regions. This reduces the need for patients to travel long distances for quality healthcare. Its presence has particularly impacted emergency and critical care services. This is because Fortis's many facilities operate 24/7 emergency departments. The company's strategic location of hospitals has helped create medical hubs in various cities. This improves the overall healthcare infrastructure of these regions.
Medical Excellence and Specialized Care
The company has made a substantial impact in bringing specialized medical treatments to India. Fortis has pioneered several complex procedures and treatments. This includes organ transplants, cardiac surgeries, and oncology treatments. Its centers of excellence have set new benchmarks in specialized care. These specialized cares are particularly in cardiology, orthopedics, neurosciences, and oncology. The company has also impacted medical tourism in India. It attracts patients from various countries and establishes India as a global healthcare destination.
Employment and Skill Development
Fortis has created significant employment opportunities in the healthcare sector. It employs thousands of medical professionals, support staff, and administrative personnel. The company's impact extends to medical education and skill development through its training programs and partnerships with educational institutions. Its presence has helped develop a skilled healthcare workforce. This contributes to the overall growth of India's healthcare sector.
Technology and Innovation Impact
The company has been instrumental in introducing cutting-edge medical technologies and innovative treatment methods in India. Fortis's adoption of robotic surgery, advanced imaging systems, and digital healthcare solutions has impacted the modernization of healthcare delivery. Its investments in healthcare technology have influenced other hospitals to upgrade their facilities. This leads to a significant improvement in healthcare technology standards across the country.
Community Health Impact
Fortis has significantly impacted community health through its preventive healthcare programs and health awareness initiatives. The company's outreach programs have helped educate communities about various health issues, preventive care, and lifestyle diseases. Its impact on public health is particularly notable during health emergencies and pandemics, where Fortis facilities have played crucial roles in disease management and treatment.
Research and Development
The company has impacted medical research through its clinical research programs and collaborations with international healthcare institutions. Fortis's participation in global medical trials and research studies has contributed to the advancement of medical knowledge and treatment protocols. Its research initiatives have particularly affected the understanding and treatment of diseases specific to the Indian population.
Fortis Healthcare's impact on India's healthcare sector extends far beyond its business operations. The company has played a transformative role in modernizing healthcare delivery. Also, it is improving access to quality medical care and setting new standards for medical excellence. Its contributions to employment, medical education, research, and community health have created lasting positive changes in the healthcare ecosystem. As the company continues to expand and innovate, its impact is likely to grow further, particularly in addressing India's healthcare challenges and improving the overall quality of healthcare services. The company's journey demonstrates how private healthcare providers can significantly contribute to a country's healthcare development while maintaining sustainable business operations.
Fortis Healthcare was founded in 1996 by Malvinder Singh and Shivinder Singh. The company has been providing healthcare services for many decades. Following a change in ownership in 2018, the company is now backed by IHH Healthcare Berhad, one of Asia's largest healthcare groups. Fortis Healthcare is headquartered in Mohali, Punjab, India.
The promoter shareholding of the company is 31.17%. The company's promoter is Northern TK Venture Pte Ltd., a subsidiary of IHH Healthcare Berhad. The company offers a comprehensive range of healthcare services. This includes multi-specialty hospital care, Diagnostic services, and Daycare specialty facilities. It also offers emergency services, critical care, preventive health programs, and organ transplantation.
Fortis Healthcare is among the top private healthcare providers in India. But it ranks second in terms of market capitalization after Apollo Hospitals Enterprise Ltd. The company operates a network of many healthcare facilities with approximately 4,000 operational beds across India.
The company's registered office is at Fortis Hospital, Sector 62, Phase VIII, Mohali, Punjab - 160062. Its registrar is located in Hyderabad, Telangana. The registrar & transfer agent of Fortis Healthcare is KFin Technologies Limited. Ravi Rajagopal is the company's chairperson and independent director.
The company's other vital managerial promoters include:
- Ashutosh Raghuvanshi
- Suvalaxmi Chakraborty
- Indrajit Banerjee
- Shailaja Chandra
The company continues expanding its presence across India through organic and inorganic growth strategies.
Impact of the Company
Fortis Healthcare has significantly impacted India's healthcare landscape since its inception. The company has transformed healthcare delivery through its integrated approach, technological advancements, and commitment to quality medical care. Its presence across multiple cities has improved healthcare accessibility. Also, it has introduced international standards of medical care to the Indian healthcare sector.Healthcare Access and Infrastructure Impact
Fortis has significantly impacted healthcare accessibility in India through its network of many hospitals across major cities and tier-2 locations. The company has brought world-class medical infrastructure to various regions. This reduces the need for patients to travel long distances for quality healthcare. Its presence has particularly impacted emergency and critical care services. This is because Fortis's many facilities operate 24/7 emergency departments. The company's strategic location of hospitals has helped create medical hubs in various cities. This improves the overall healthcare infrastructure of these regions.
Medical Excellence and Specialized Care
The company has made a substantial impact in bringing specialized medical treatments to India. Fortis has pioneered several complex procedures and treatments. This includes organ transplants, cardiac surgeries, and oncology treatments. Its centers of excellence have set new benchmarks in specialized care. These specialized cares are particularly in cardiology, orthopedics, neurosciences, and oncology. The company has also impacted medical tourism in India. It attracts patients from various countries and establishes India as a global healthcare destination.
Employment and Skill Development
Fortis has created significant employment opportunities in the healthcare sector. It employs thousands of medical professionals, support staff, and administrative personnel. The company's impact extends to medical education and skill development through its training programs and partnerships with educational institutions. Its presence has helped develop a skilled healthcare workforce. This contributes to the overall growth of India's healthcare sector.
Technology and Innovation Impact
The company has been instrumental in introducing cutting-edge medical technologies and innovative treatment methods in India. Fortis's adoption of robotic surgery, advanced imaging systems, and digital healthcare solutions has impacted the modernization of healthcare delivery. Its investments in healthcare technology have influenced other hospitals to upgrade their facilities. This leads to a significant improvement in healthcare technology standards across the country.
Community Health Impact
Fortis has significantly impacted community health through its preventive healthcare programs and health awareness initiatives. The company's outreach programs have helped educate communities about various health issues, preventive care, and lifestyle diseases. Its impact on public health is particularly notable during health emergencies and pandemics, where Fortis facilities have played crucial roles in disease management and treatment.
Research and Development
The company has impacted medical research through its clinical research programs and collaborations with international healthcare institutions. Fortis's participation in global medical trials and research studies has contributed to the advancement of medical knowledge and treatment protocols. Its research initiatives have particularly affected the understanding and treatment of diseases specific to the Indian population.
Fortis Healthcare's impact on India's healthcare sector extends far beyond its business operations. The company has played a transformative role in modernizing healthcare delivery. Also, it is improving access to quality medical care and setting new standards for medical excellence. Its contributions to employment, medical education, research, and community health have created lasting positive changes in the healthcare ecosystem. As the company continues to expand and innovate, its impact is likely to grow further, particularly in addressing India's healthcare challenges and improving the overall quality of healthcare services. The company's journey demonstrates how private healthcare providers can significantly contribute to a country's healthcare development while maintaining sustainable business operations.
View More
FAQ’s
What is the share price of Fortis Healthcare Ltd today?
Fortis Healthcare Ltd share price as on 31 Jan 2025 is ₹
648.55
What is the Market Cap of Fortis Healthcare Ltd?
The market cap of Fortis Healthcare Ltd stock is ₹48,902.41 Cr.
What is the PE Ratio of Fortis Healthcare Ltd?
The Price to Earnings (P/E) Ratio of Fortis Healthcare Ltd is 159.05
What is the PB Ratio of Fortis Healthcare Ltd?
The Price to Book (P/B) Ratio of Fortis Healthcare Ltd is 3.49
What is the 52 week high of Fortis Healthcare Ltd Share Price?
The 52 week high of Fortis Healthcare Ltd share price stands at ₹744.50
What is the 52 week low of Fortis Healthcare Ltd Share Price?
The 52 week low of Fortis Healthcare Ltd share price stands at ₹375.05
Open Free
Demat Account!
Enjoy ₹11 Brokerage on Stocks Delivery
Equity, F&O and
DP Charges
